These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7578380)

  • 21. [Diffuse colon linitis secondary to a gastric adenocarcinoma. Detected during diarrhea treated with octreotide].
    Audigier C; Jacob P; Tanière P; Boulez J; Chayvialle JA; Lombard-Bohas C
    Gastroenterol Clin Biol; 1998 Apr; 22(4):471-3. PubMed ID: 9762281
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease.
    Ely P; Dunitz J; Rogosheske J; Weisdorf D
    Am J Med; 1991 Jun; 90(6):707-10. PubMed ID: 2042686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constipation and diarrhea in patients with cancer.
    Solomon R; Cherny NI
    Cancer J; 2006; 12(5):355-64. PubMed ID: 17034672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E; Karaoglu A
    Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S
    Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
    Wadler S; Benson AB; Engelking C; Catalano R; Field M; Kornblau SM; Mitchell E; Rubin J; Trotta P; Vokes E
    J Clin Oncol; 1998 Sep; 16(9):3169-78. PubMed ID: 9738589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
    Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
    J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide for symptomatic treatment of diarrhea due to cytomegalovirus colitis.
    Bartels MC; Mergenhagen KA
    Ann Pharmacother; 2011 Jan; 45(1):e4. PubMed ID: 21189368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of probiotics for prevention of radiation-induced diarrhea.
    Delia P; Sansotta G; Donato V; Frosina P; Messina G; De Renzis C; Famularo G
    World J Gastroenterol; 2007 Feb; 13(6):912-5. PubMed ID: 17352022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
    Geller RB; Gilmore CE; Dix SP; Lin LS; Topping DL; Davidson TG; Holland HK; Wingard JR
    Am J Hematol; 1995 Nov; 50(3):167-72. PubMed ID: 7485077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.
    Saliba F; Hagipantelli R; Misset JL; Bastian G; Vassal G; Bonnay M; Herait P; Cote C; Mahjoubi M; Mignard D; Cvitkovic E
    J Clin Oncol; 1998 Aug; 16(8):2745-51. PubMed ID: 9704727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidance on the management of diarrhoea during cancer chemotherapy.
    Andreyev J; Ross P; Donnellan C; Lennan E; Leonard P; Waters C; Wedlake L; Bridgewater J; Glynne-Jones R; Allum W; Chau I; Wilson R; Ferry D
    Lancet Oncol; 2014 Sep; 15(10):e447-60. PubMed ID: 25186048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding and managing chemotherapy-induced diarrhea.
    Saltz LB
    J Support Oncol; 2003; 1(1):35-46; discussion 38-41, 45-6. PubMed ID: 15352641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent Diarrhea after Celiac Plexus Block in a Pancreatic Cancer Patient: Case Report and Literature Review.
    Yang A; Brown J; Mak E
    J Palliat Med; 2016 Jan; 19(1):83-6. PubMed ID: 26381724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of pheochromocytoma with renal artery stenosis and post-surgical watery diarrhea.
    Blasi C; D'Amore F; Delle Fave G; Massa R; Reale MG; Caliumi C; Letizia C
    Horm Res; 2001; 56(3-4):130-3. PubMed ID: 11847476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the long-acting somatostatin analogue SMS 201-995 in an infant with intractable diarrhea.
    Hunziker UA; Superti-Furga A; Zachmann M; Del Pozo E; Shmerling D; Prader A
    Helv Paediatr Acta; 1988 Aug; 43(1-2):103-9. PubMed ID: 2844705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New strategies for the prevention and reduction of cancer treatment-induced diarrhea.
    Anthony L
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):17-21. PubMed ID: 14702929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
    Pai V; Porter K; Ranalli M
    Pediatr Blood Cancer; 2011 Jan; 56(1):45-9. PubMed ID: 21108438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
    Cascinu S; Fedeli A; Fedeli SL; Catalano G
    J Clin Oncol; 1993 Jan; 11(1):148-51. PubMed ID: 8418225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide.
    Nakabayashi H; Fujii S; Miwa U; Seta T; Takeda R
    Arch Intern Med; 1994 Aug; 154(16):1863-7. PubMed ID: 8053756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.